24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Adicet Bio
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
09:32
“Suffocating innovation”: Intel’s new CEO dismantles hierarchy
18:17
“Our goal is to build a generational company,” says Deel CEO amid espionage case
16:36
Tenable names co-CEOs to lead after Amit Yoran’s death
16:35
AU10TIX appoints Yair Tal as CEO
More stories
Buzz
Most popular
Daily
Weekly
1
Intel’s breakup begins with sale of $8.75B-valued Altera to private equity giant Silver Lake
2
Layoffs loom as Intel’s new CEO moves to fix slow decision-making and chip production
3
Deel CEO Alex Bouaziz surfaces in Dubai as Rippling struggles to serve lawsuit
4
Check Point's X-Factor: Can Nadav Zafrir wake the sleeping giant?
5
Torq buys stealth Israeli AI startup Revrod for over $20M to power next-gen security ops
More news
Adicet Bio
1 stories about Adicet Bio
Allogenic Immunotherapy Company Adicet Bio Raises $80 Million
02.10.19
|
Meir Orbach
Founded by Israeli chemist Aya Jakobovits, Adicet develops universal immune cell therapies based on gamma delta T cells to treat different forms of cancer
